ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca.

With seasonal allergies affecting millions of people across the United States, many individuals considering LASIK eye surgery are left wondering whether their allergy symptoms might interfere with the ...